Holen Sie sich die Stockscreener-App
2.23
4.67%
-0.10
Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
13.19%
21.66
|
24.95 | 25.14 | 21.44 | 17.67 |
| Operating Income/Loss |
13.19%
-21.66
|
-24.95 | -25.14 | -21.44 | -17.67 |
| Nonoperating Income/Loss |
6.64%
1.982
|
2.123 | 2.699 | 2.639 | 1.182 |
| Income/Loss From Continuing Operations Before Tax |
13.80%
-19.68
|
-22.83 | -22.44 | -18.80 | -16.49 |
| Income/Loss From Continuing Operations After Tax |
13.80%
-19.68
|
-22.83 | -22.44 | -18.80 | -16.49 |
|
Net Income/Loss
|
13.80%
-19.68
|
-22.83 | -22.44 | -18.80 | -16.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,466%
38.35
|
1.4944 | 38.11 | 36.13 | 22.59 |
| Diluted Average Shares |
2,466%
38.35
|
1.4944 | 38.11 | 36.13 | 22.59 |
| Basic Earnings Per Share |
13.56%
-0.51
|
-0.59 | -0.59 | -0.52 | -0.73 |
| Diluted Earnings Per Share |
13.56%
-0.51
|
-0.59 | -0.59 | -0.52 | -0.73 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.94%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):